CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Grindeks AS Company Snapshot
Grindeks AS operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Grindeks AS with three other pharmaceutical manufacturers in Europe: Opus Global Nyrt of Hungary (2017 sales of 42.55 billion Hungarian Forints [US$148.08 million] of which 70% was Media), EastPharma Ltd of Turkey (801.44 million Turkish Liras [US$148.46 million] of which 93% was Human Pharma), and Deva Holding AS which is also based in Turkey (800.30 million Turkish Liras [US$148.25 million] of which 93% was Pharmaceuticals).

Sales Analysis. During the year ended December of 2017, sales at Grindeks AS were 132.41 million Euro (US$149.28 million). This is an increase of 25.7% versus 2016, when the company's sales were 105.37 million Euro. Sales of Final Dosage Forms saw an increase of 26.7% in 2017, from 99.02 million Euro to 125.49 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Grindeks AS
  Stock Performance Chart for Grindeks AS
 
  Stock Data: Recent Stock Performance:
  Current Price (12/14/2018): 6.40
(Figures in Euro)
1 Week 8.1%   13 Weeks 10.3%  
4 Weeks -6.2%   52 Weeks -6.6%  
 
Grindeks AS Key Data:
  Ticker: GRD1R Country: Latvia
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 132,410,851
(Year Ending Jan 2018).
Employees: 1,355
  Currency: Euro Market Cap: 61,344,000
  Fiscal Yr Ends: December Shares Outstanding: 9,585,000
  Share Type: Closely Held Shares: 6,958,711
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.